Cencora, Inc. (COR) stock
Close on Nov 11, 2026Market cap $66.77BP/E 26.0Yield 0.63%
Cencora, Inc. grew revenue 5.1% to $332.77B over the twelve months to Jun 30, 2026. Operating income rose 11.1% to $3.04B, moving the operating margin from 0.9% to 0.9%. Free cash flow was $4.06B, up 255.7% from a year earlier. At the latest close the market valued the company at $66.77B, 26.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $66.77B
- P/E ratio
- 26.0
- Price to sales
- 0.20
- Price to book
- 21.88
- Dividend yield
- 0.63%
- Free cash flow yield
- 6.08%
Fundamentals
- Revenue
- $332.77B
- Net income
- $2.62B
- EPS, diluted
- $13.47
- Free cash flow
- $4.06B
- Book value per share
- $15.73
- Diluted shares
- 194M
Trading
- Next earnings
- Feb 3, 2027 (estimated, before the open)
- Previous close
- $348.71
- Open
- $345.67
- Day's range
- $344.50 – $350.17
- Volume
- 845,647
- Average volume (20 days)
- 1,451,391
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.33
- 52-week range
- $244.82 – $377.54
- RSI (14 days)
- 61.4
- Volatility (1 year)
- 31.8%
- Relative volume
- 0.62×
- WACC
- 7.0%
On 2 of our idea lists: Mega-cap growers, Dividend growers
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | COR | S&P 500 | Difference | COR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.0% | -2.4% | +10.4 pts | ||
| 3 months | +5.0% | -1.2% | +6.1 pts | ||
| Year to date | +4.2% | +12.3% | −8.1 pts | ||
| 1 year | -3.4% | +12.4% | −15.9 pts | ||
| 3 years | +81.1% | +78.8% | +2.3 pts | +21.9% | +21.4% |
| 5 years | +195.8% | +75.2% | +120.7 pts | +24.2% | +11.9% |
| 10 years | +493.6% | +311.1% | +182.5 pts | +19.5% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cencora filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Update
- Results
- Update
About Cencora
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora, Inc. sources and distributes brand-name, specialty, and generic pharmaceuticals, over-the-counter medications, and home healthcare supplies for human and animal health. The company also provides commercialization, consulting, packaging, pharmacy automation, and specialty logistics solutions. It operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. Customers include health systems, acute care hospitals, retail and mail-order pharmacies, medical clinics, physician practices, veterinarians, and biopharmaceutical manufacturers.
Company profile, executives and historyCencora stock: common questions
What is Cencora's stock price?
COR closed at $349.88 on Nov 11, 2026, up 0.34% on the day. Over the past 52 weeks it traded between $244.82 and $377.54.
What is Cencora's market cap?
Cencora was worth $66.77B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is COR's P/E ratio?
COR trades at 26.0 times earnings, based on diluted earnings per share of $13.47 over the twelve months to Jun 30, 2026.
How much revenue does Cencora make?
Cencora reported revenue of $332.77B for the twelve months to Jun 30, 2026, up 5.1% from a year earlier.
Does Cencora pay a dividend?
Yes. Cencora paid $2.20 per share over the last twelve months, a yield of 0.63% at the latest price, and has raised its annual dividend 17 years in a row.
When does Cencora report earnings next?
Cencora is expected to report Q1 FY2027 results on Feb 3, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has COR stock performed over the past year?
Including dividends, COR returned -3.4% over the past year, against +12.4% for the S&P 500.
How many COR shares are sold short?
3M shares were sold short at the latest FINRA report, 1.75% of the float, or 2.6 days of average trading volume.
Who are Cencora's competitors?
Companies most similar to Cencora by business, industry and size include CAH, MCK, CI, RDY, CVS.
See a number that looks wrong?